UKApr 2017
Enterprise Therapeutics closed a funding round (amount undisclosed) in Apr 2017. The company is based in UK. Investors in the round: Cystic fibrosis Trust. Data as of Nov 2026.
Amount raised
—
undisclosed
Native amount
—
Stage
Other
Investors
1
Provenance & confidence
UnverifiedAmount
Amount undisclosed or unconverted.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.